Time series changes, and things become abundant. Time flies by, and the busy and fulfilling work comes to an end. In order to celebrate the fruitful achievements of the previous stage and play a new chapter in the next stage, PreMed (Beijing) Laboratory Technology Co., Ltd. held an annual meeting in Beijing from January 15th to 20th.
At the beginning of the meeting, Mr. Fan, the General Manager of Primadi, wrote a year-end report titled "2023, Striving Forward" with keywords: post pandemic era, recession and recovery. In the context of a sluggish market economy, Primadi's performance in 2023 increased by 66% year-on-year. While summarizing the year 2023, General Manager Fan also proposed the focus of work for 2024.


- Conference Preview | Premedlab invites you to attend the 12th Munich Shanghai Analytical Biochemistry Exhibition
- Conference Preview | PremedLab invites you to attend the Beijing Yizhuang Summit on Cell Genes and Nucleic Acid Drugs
- Conference Preview | PremedLab invites you to attend the 14th Annual Meetting of CSSCR
- Binaree Organization Transparency Reagent - Summer Promotion Begins!
- The new high-precision SPR detection platform for 2024 is here!!
- Meeting Announcement | Premedlab cordially invites you to participate in the 2nd Molecular Interaction Innovation Technology and Frontier Application Network Seminar
- Application for limited time of Corebiogenesis trial installation | GMP grade FGF-2 STAB with no animal source, thermal stability, and high activity - new gold standard for stem cell culture
- CELLnTEC new product launch | Corticosteroid free epithelial cell proliferation medium

